Medicare Enrolled

Dr. Balveen Singh, D.O.

Psychiatry · New City, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
216 CONGERS RD BLDG 3, New City, NY 10956
8454806678
Registered in NPPES since 2010
NPI: 1164753745 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Balveen Singh is a psychiatry specialist in New City, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 564 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Singh received a total of $156,172 from 29 pharmaceutical and/or device companies across 710 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration ▲ Top 25% volume in NY $156,172 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
564
Medicare services
Top 25% in NY for psychiatry
Not available
Unique patients (not deduplicated)
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
110 $68 $157
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
107 $118 $181
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
96 $79 $180
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
84 $60 $120
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
77 $78 $150
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
65 $98 $222
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
25 $41 $75
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$156,172
Total received (2018-2024)
Avg $22,310/year across 7 years
Top 1% in NY for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
710
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$76,371
2023
$39,922
2022
$27,728
2021
$3,863
2020
$3,071
2019
$4,707
2018
$510

Payments by company (2024)

Otsuka America Pharmaceutical, Inc.
$48,418
Axsome Therapeutics, Inc.
$24,672
Neuronetics, Inc.
$1,718
ABBVIE INC.
$455
Alkermes, Inc.
$269
Janssen Pharmaceuticals, Inc
$228
Neurocrine Biosciences, Inc.
$185
Almatica Pharma LLC
$117
Indivior Inc.
$106
Corium, LLC
$50
Lundbeck LLC
$48
Orexo US, Inc.
$44
E.R. Squibb & Sons, L.L.C.
$43
Boston Scientific Corporation
$16
Top 3 companies account for 98.0% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$118,332
Axsome Therapeutics, Inc.
$24,977
Alkermes, Inc.
$2,120
Neuronetics, Inc.
$1,745
Neurocrine Biosciences, Inc.
$1,392
Sunovion Pharmaceuticals Inc.
$1,336
Janssen Pharmaceuticals, Inc
$961
AbbVie Inc.
$926
ITI, Inc.
$909
ABBVIE INC.
$859
Lundbeck LLC
$649
Corium, LLC
$546
Allergan, Inc.
$260
Indivior Inc.
$209
Abbott Laboratories
$162
JAZZ PHARMACEUTICALS INC.
$147
Allergan Inc.
$128
Almatica Pharma LLC
$117
Otsuka Pharmaceutical Development & Commercialization, Inc.
$84
Teva Pharmaceuticals USA, Inc.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$48
Orexo US, Inc.
$44
E.R. Squibb & Sons, L.L.C.
$43
BioXcel Therapeutics, Inc.
$25
Avanir Pharmaceuticals, Inc.
$22
PFIZER INC.
$22
Neos Therapeutics, LP
$21
Alfasigma USA, Inc.
$18
Boston Scientific Corporation
$16
Top 3 companies account for 93.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aristada 441 mg · Auvelity · Azstarys · CAPLYTA · COBENFY · IGALMI · INGREZZA · INVEGA SUSTENNA · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · PAXLOVID · PERSERIS · REXULTI · SPRAVATO · SUNOSI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRINTELLIX · VIVITROL · VRAYLAR · Vivitrol · Zubsolv
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in New City?
Compare psychiatrists in the New City area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
1,571
County median income
$110,631
Nearest hospital to ZIP centroid (approximate)
HELEN HAYES HOSPITAL
4.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Singh is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Singh performed 110 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $156,172 from 29 companies across 710 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other psychiatrists in New City?
Dr. Singh's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →